RAC 0.63% $1.59 race oncology ltd

Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-144

  1. 7,023 Posts.
    lightbulb Created with Sketch. 873

    So this is where your answer shows the spin

    R110 was run and stopped at phase two…. (Currently the other company is paused at phase two but I am not the one who is talking about them here you all seem to be by the way)

    R110 isn’t up to scratch to take to market so the spin is “we identify a bigger market”

    So now you have R220….. Not rocket science is it

    A bigger market is great!! Just hope someone wants it at end of phase two like the rest of the speculative play ASX bio field as this is how they play

    Let’s go RAC!! RAC to the moon!! Lambo club!! High five!! I suspect this what you want to hear?? LOL
    Last edited by Bluegumnuts: 09/07/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.